Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh (original) (raw)
Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Ann Epidemiol. 2007;17:863–5. ArticlePubMed Google Scholar
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1226–31. Article Google Scholar
Clark JM, Brancati FL, Dieh AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57. ArticlePubMed Google Scholar
Amarpurkar DN, Hashimoto E, Lesman LA, Sollano JD, Chan PJ, Goh KL. Asia-pacific working party on nonalcoholic fatty liver disease. How common is NAFLD in the Asia-pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788–93. Article Google Scholar
Younossi ZM, Stepanovo M, Fang Y, Younossi Y, Mir H, Shrishard M. Changes in prevalence of the most common causes of chronic liver disease in United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–30. ArticlePubMed Google Scholar
Amarpurkar D, Kumani P, Patel N, et al. Prevalence of nonalcoholic fatty liver disease, population based study. Ann Hepatol. 2007;61:161–3. Google Scholar
Fabbini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease biochemical, metabolic and clinical implications. Hepatology. 2010;51:679–89. Article Google Scholar
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–85. ArticlePubMedCAS Google Scholar
Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subject with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63. ArticlePubMedCAS Google Scholar
Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver disease and significant liver disease. Hepatology. 2010;51:1593–602. ArticlePubMedCAS Google Scholar
Merra F, Bertolani C. Adipokines in liver diseases. Hepatology. 2009;50:957–69. Article Google Scholar
Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2012;11:478–86. PubMed Google Scholar
Francazani AL, Valenti L, Buigianesi E, et al. Risk of NASH and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol. 2011;54:1244–49. Article Google Scholar
Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP. Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol. 2007;102:399–408. ArticlePubMedCAS Google Scholar
Madan K, Batra Y, Gupta SD, et al. Nonalcoholic fatty liver disease may not be a severe disease at apresentation among Asian Indians. World J Gastroenterol. 2006;12:3400–5. PubMedPubMed Central Google Scholar
Belleantini S, Marino M. Epidemiology and natural history of nonalcoholic fatty liver disease. Ann Hepatol. 2009;8 Suppl 1:S4–8. Google Scholar
Sing DK, Sakhuja P, Malhotra V, Gondal R, Sarin SK. Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with NASH. Dig Dis Sci. 2007;52:2368–74. Article Google Scholar
Succuro E, Marini MA, Frontini S, et al. Insulin secretion in metabolically healthy but obese individuals. Obesity (Silver Spring). 2008;16:1881–6. Article Google Scholar
Heng D, Ma S, Lee JJ, et al. Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis. 2006;186:367–73. ArticlePubMedCAS Google Scholar
Expert WHO. Consultation. appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63. Article Google Scholar
Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74. ArticlePubMedCAS Google Scholar
Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21. ArticlePubMed Google Scholar
Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462–8. ArticlePubMedCAS Google Scholar
Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48:792–8. ArticlePubMedCAS Google Scholar
Duseja A, Das A, Das R, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci. 2007;52:2368–74.
Bajaj S, Nigam P, Luthra A, et al. A case–control study on insulin resistance, metabolic co-variates and prediction score in non-alcoholic fatty liver disease. Indian J Med Res. 2009;129:285–92. PubMedCAS Google Scholar
Agarwal AK, Jain V, Singla S, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India. 2011;59:351–4. PubMedCAS Google Scholar
Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–7. ArticlePubMedCAS Google Scholar
Petersen KF, Dufour S, Feng J, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci. 2006;103:18273–27. ArticlePubMedCASPubMed Central Google Scholar
Kumar R, Rastogi A, Sharma MK, et al. Clinicopathological characteristics and metabolic profile of nonalcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocr Metab. 2013;17:665–71. Article Google Scholar
Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23. ArticlePubMed Google Scholar
Uchil D, Pipalia D, Chawla M, et al. Non-alcoholic fatty liver disease (NAFLD): the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009;57:201–4. PubMed Google Scholar
Das SK, Balakrishnan V. Role of cytokines in the pathogenesis of non-alcoholic fatty liver disease. Indian J Clin Biochem. 2011;26:202–9.
Viswanathan V, Kadiri M, Medipudi S, Kumpatla S. Association of non-alcoholic fatty liver disease with microvascular and macrovascular complications in south Indian diabetic subjects. Int J Diabetes Dev C. 2010;30:208–12. Article Google Scholar
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112. ArticlePubMedCAS Google Scholar
Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–50. ArticlePubMedCAS Google Scholar
Kim HJ, Kim HJ, Lee KE, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med. 2004;164:2169–75. ArticlePubMed Google Scholar
Santoro N, Kursawe R, D’Adamo E, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology. 2010;52:1281–90. ArticlePubMedCASPubMed Central Google Scholar
Alam SL, Noor-E-Alam SM, Chowdhury ZR, Alam M, Kabir J. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. World J Hepatol. 2013;5:281–7. ArticlePubMedPubMed Central Google Scholar
Wong VW, Wong GL, Tsang SW, et al. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther. 2009;29:387–96. ArticlePubMedCAS Google Scholar
Neuschwander-Tetri BA, Clark JM, Bass NM, et al. NASH clinical research network. clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010;52:913–24. ArticlePubMedCASPubMed Central Google Scholar
Alam S, Ahmad N, Mustafa G, et al. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B. Liver Int. 2011;31:824–30. ArticlePubMedCAS Google Scholar